Skip to main content

J. Goldman & Co LP

Position in IONS — Ionis Pharmaceuticals Inc

CIK 1412741 NEW YORK, NY

Position in IONS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$17,665,673
+$12,314,752 QoQ
Shares Held
235,260
+247.8% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in IONS Over Time

Shares Held

Position Value (USD)

Derivatives in IONS

reported options exposure · as of Mar 31, 2026
CallValue
$1,501,800
CallShares
20,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

J. Goldman & Co LP holds $186,588,929 across 52 Biotechnology names. IONS ranks #3 (9.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 IONS
Ionis Pharmaceuticals Inc
This page
235,260 $17,665,673

All Filings in IONS

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $17,665,673 235,260
2026-03-31 $1,501,800 20,000
2025-12-31 $5,350,921 67,639
2025-12-31 $1,977,750 25,000
2025-09-30 $6,293,273 96,198
2025-06-30 $5,834,915 147,682
2025-06-30 $7,506,900 190,000
2025-03-31 $9,285,420 307,770
2024-12-31 $21,238,165 607,499
2024-09-30 $24,413,204 609,416
2024-09-30 $3,637,448 90,800
2024-06-30 $6,910,700 145,000
2024-06-30 $834,145 17,502
2024-06-30 $14,259,872 299,200
2024-03-31 $10,032,230 231,424
2024-03-31 $7,334,820 169,200